Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Kelder

Showing results (121-130 of 122) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 122 results.
The Journal of Infectious Diseases|February 2, 2023
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 ParticipantsStacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
The Journal of Infectious Diseases|May 6, 2022
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response SurveyMichael D Swartz, Stacia M DeSantis, Ashraf Yaseen, et al.
Pageof 13

Showing results (121-130 of 122) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 122 results.
The Journal of Infectious Diseases|February 2, 2023
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 ParticipantsStacia M DeSantis, Ashraf Yaseen, Tianyao Hao, et al.
The Journal of Infectious Diseases|May 6, 2022
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response SurveyMichael D Swartz, Stacia M DeSantis, Ashraf Yaseen, et al.
Pageof 13